One advantage is using a more physiological context of a naturally EGFR-dependent lung cancer cell line while a disadvantage is that our ectopic expression system leads to co-expression of two forms of EGFR—the endogenous exon 19 deletion mutant and the exogenously introduced missense mutant form. The gene discussed is EGFR; the disease is lung carcinoma.